192 related articles for article (PubMed ID: 33057072)
1. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage.
Ueta M; Nishigaki H; Sotozono C; Yokoi N; Mizushima K; Naito Y; Kinoshita S
Sci Rep; 2020 Oct; 10(1):17239. PubMed ID: 33057072
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage.
Ueta M; Sotozono C; Nishigaki H; Ohsako S; Yokoi N; Mizushima K; Naito Y; Kinoshita S
BMJ Open Ophthalmol; 2019; 4(1):e000254. PubMed ID: 31276031
[TBL] [Abstract][Full Text] [Related]
3. Expression of prostaglandin E
Mieno H; Ueta M; Yamada K; Yamanaka Y; Nakayama T; Watanabe A; Kinoshita S; Sotozono C
Br J Ophthalmol; 2020 Jul; 104(7):1022-1027. PubMed ID: 31000507
[TBL] [Abstract][Full Text] [Related]
4. Analysis of circRNA profiles and clinical value in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Lv P; Huang J; Yang Q; Yang T; Cao X; Liu O; Zhang Z
Exp Dermatol; 2023 Dec; 32(12):2084-2093. PubMed ID: 37750014
[TBL] [Abstract][Full Text] [Related]
5. Ocular surface inflammation mediated by innate immunity.
Ueta M; Kinoshita S
Eye Contact Lens; 2010 Sep; 36(5):269-81. PubMed ID: 20703156
[TBL] [Abstract][Full Text] [Related]
6. Positive regulation of innate immune response by miRNA-let-7a-5p.
Ueta M; Nishigaki H; Komai S; Mizushima K; Tamagawa-Mineoka R; Naito Y; Katoh N; Sotozono C; Kinoshita S
Front Genet; 2022; 13():1025539. PubMed ID: 36685889
[No Abstract] [Full Text] [Related]
7. Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders.
Ueta M; Sotozono C; Yokoi N; Inatomi T; Kinoshita S
PLoS One; 2011; 6(9):e25209. PubMed ID: 21966456
[TBL] [Abstract][Full Text] [Related]
8. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Ueta M
Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
[No Abstract] [Full Text] [Related]
9. Exosomal microRNAs from PBMCs stimulated with culprit drugs enhanced keratinocyte cell death in Stevens-Johnson syndrome/toxic epidermal necrolysis.
Suthumchai N; Buranapraditkun S; Thantiworasit P; Rerknimitr P; Wongpiyabovorn J; Khanaraksombat S; Reantragoon R; Klaewsongkram J
J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1375-1384. PubMed ID: 36840393
[TBL] [Abstract][Full Text] [Related]
10. Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study.
Ueta M; Sotozono C; Yamada K; Yokoi N; Inatomi T; Kinoshita S
BMJ Open; 2012; 2(5):. PubMed ID: 23065448
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.
Ueta M
Front Med (Lausanne); 2021; 8():651247. PubMed ID: 34869401
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity of the ocular surface and ocular surface inflammatory disorders.
Ueta M
Cornea; 2008 Sep; 27 Suppl 1():S31-40. PubMed ID: 18813073
[TBL] [Abstract][Full Text] [Related]
13. [Conjunctival Fas-FasL expression in chronic Stevens-Johnson syndrome].
Chen S; Jiang Y; Wang Z; Li Y
Zhonghua Yan Ke Za Zhi; 2014 Sep; 50(9):691-4. PubMed ID: 25533561
[TBL] [Abstract][Full Text] [Related]
14. Altered retinoid metabolism gene expression in chronic Stevens-Johnson syndrome.
Srividya G; Angayarkanni N; Iyer G; Srinivasan B; Agarwal S
Br J Ophthalmol; 2019 Aug; 103(8):1015-1023. PubMed ID: 31023710
[TBL] [Abstract][Full Text] [Related]
15. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand.
Jongkhajornpong P; Lekhanont K; Pisuchpen P; Chantaren P; Puangsricharern V; Prabhasawat P; Suphapeetiporn K; Kinoshita S; Ueta M
Br J Ophthalmol; 2018 Sep; 102(9):1303-1307. PubMed ID: 29706602
[TBL] [Abstract][Full Text] [Related]
16. Elevation of conjunctival epithelial CD45INTCD11b⁺CD16⁺CD14⁻ neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis.
Williams GP; Tomlins PJ; Denniston AK; Southworth HS; Sreekantham S; Curnow SJ; Rauz S
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4578-85. PubMed ID: 23737478
[TBL] [Abstract][Full Text] [Related]
17. Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.
Ueta M
Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES183-DES191. PubMed ID: 30481825
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC.
Ueta M
Front Genet; 2022; 13():912478. PubMed ID: 35899189
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Toll-like receptor 5 expression in the conjunctival epithelium of various human ocular surface diseases.
Yamada K; Ueta M; Sotozono C; Yokoi N; Inatomi T; Kinoshita S
Br J Ophthalmol; 2014 Aug; 98(8):1116-9. PubMed ID: 24820048
[TBL] [Abstract][Full Text] [Related]
20. Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation.
Gurumurthy S; Iyer G; Srinivasan B; Agarwal S; Angayarkanni N
Br J Ophthalmol; 2018 Feb; 102(2):169-176. PubMed ID: 28689166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
